Funding

Cambridge Nucleomics has successfully closed an oversubscribed £550 k pre-seed round led by Cambridge Angels with participation from Cambridge Technology Capital. In a strong vote of confidence toward Nucleomics' founding team and revolutionary modular soluble nanoarray (MSN) technology platform, this capital injection…